日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD

雾化吸入干扰素β-1a(SNG001)治疗慢性阻塞性肺疾病病毒性急性加重

Monk, Phillip D; Brookes, Jody L; Tear, Victoria J; Batten, Toby N; Newall, Clare; Mankowski, Marcin; Crooks, Michael G; Singh, Dave; Chaudhuri, Rekha; Leaker, Brian; Lunn, Kerry; Reynolds, Sophie; Dudley, Sarah; Gabbay, Felicity J; Holgate, Stephen T; Djukanovic, Ratko; Wilkinson, Thomas Ma

Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study

雾化吸入干扰素β-1a (SNG001)治疗住院COVID-19患者:SPRINTER III期研究

Monk, Phillip D; Brookes, Jody L; Tear, Victoria J; Batten, Toby N; Mankowski, Marcin; Adzic-Vukicevic, Tatjana; Crooks, Michael G; Dosanjh, Davinder P S; Kraft, Monica; Brightling, Christopher E; Gabbay, Felicity J; Holgate, Stephen T; Djukanovic, Ratko; Wilkinson, Tom M A

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

吸入雾化干扰素β-1a (SNG001)治疗SARS-CoV-2感染的安全性和有效性:一项随机、双盲、安慰剂对照的II期试验

Monk, Phillip D; Marsden, Richard J; Tear, Victoria J; Brookes, Jody; Batten, Toby N; Mankowski, Marcin; Gabbay, Felicity J; Davies, Donna E; Holgate, Stephen T; Ho, Ling-Pei; Clark, Tristan; Djukanovic, Ratko; Wilkinson, Tom M A

Molecular, proteomic and immunological parameters of allergens provide inclusion criteria for new candidates within established grass and tree homologous groups

过敏原的分子、蛋白质组和免疫学参数为已建立的禾本科和树木同源类群中新候选过敏原的纳入提供了标准。

Heath, Matthew D; Collis, Joe; Batten, Toby; Hutchings, James W; Swan, Nicola; Skinner, Murray A

Cross-reactivity in Grasses: Biochemical Attributes Define Exemplar Relevance.

草类交叉反应性:生化属性定义范例相关性

Bullimore Alan, Batten Toby, Hewings Simon, Fischer von Weikersthal-Drachenberg Karl Juergen, Skinner Murray